12:00 AM
 | 
Apr 21, 2008
 |  BC Week In Review  |  Company News  |  Deals

Dynogen, Apex Bioventures Acquisition Corp. deal

Special purpose acquisition company Apex and Dynogen terminated a deal under which Apex would have acquired Dynogen for $98...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >